Company Filing History:
Years Active: 2018
Title: Innovations by Thomas DiRaimondo
Introduction
Thomas DiRaimondo is an accomplished inventor based in Orinda, California. He has made significant contributions to the field of biomedical research, particularly in the modulation of tissue transglutaminase activation in various diseases. His work has the potential to impact the treatment of inflammatory disorders.
Latest Patents
DiRaimondo holds a patent for "Modulation of tissue transglutaminase activation in disease." This patent includes compositions and methods for modulating the physiological activation of tissue transglutaminase (TG2). The methods can involve inhibiting the activity of TG2 associated with inflammatory disorders, including sepsis, ischemic reperfusion injury, and renal fibrosis.
Career Highlights
He is affiliated with Leland Stanford Junior University, where he conducts research and collaborates with other experts in the field. His innovative approach to understanding TG2's role in disease has garnered attention in the scientific community.
Collaborations
DiRaimondo has worked alongside notable colleagues such as Chaitan Khosla and Cornelius Kloeck. Their combined expertise contributes to advancing research in the modulation of tissue transglutaminase.
Conclusion
Thomas DiRaimondo's work exemplifies the intersection of innovation and medical research, with his patent offering promising avenues for treating inflammatory disorders. His contributions continue to shape the future of biomedical science.